Q-omics provides the consensus-scored RPL17P19 profile across patient tissues and cancer cell-line models. RPL17P19 expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, RPL17P19 RNA expression shows 7,801 significant gene co-expression associations, with the highest sampling consensus in SARC. Together, these results highlight BLCA, and SARC as cancer lineages where RPL17P19 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RPL17P19 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RPL17P19 survival associations across molecular data types. RPL17P19 RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RPL17P19 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	12	KIRP (72)	view →

This table ranks reproducible RPL17P19 RNA expression–survival associations across cancer types. High RPL17P19 expression shows unfavorable associations in BLCA, KIRP, CESC, STAD and BRCA, but favorable associations in GBM. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for RPL17P19 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	IV	0.120	0.599	<.001	72	view →
KIRP	OS	Tertile	All	0.161	0.904	<.001	72	view →
CESC	DFS	Tertile	III,IV	0.190	0.727	.006	54	view →
STAD	OS	Tertile	II,III,IV	0.263	0.726	<.001	48	view →
BRCA	DFS	Tertile	II,III,IV	0.833	0.943	.013	24	view →
GBM	DFS	Tertile	All	0.434	0.171	.001	24	view →

Pink = unfavorable, green = favorable. all 12 lineages →

RPL17P19-BLCA (OS)

Kaplan–Meier survival curve for RPL17P19 RNA expression in BLCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RPL17P19 in patient tissues and cancer cell lines. In patient samples, RPL17P19 shows the broadest associations at the RNA and protein expression levels, with SARC recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	7,801	SARC (2877)	view →
Protein (mass-spec)	6,714	CCRCC (2563)	view →